Dr. Lawrence E. Feldman
Claim this profileUniversity of Illinois
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
29 reported clinical trials
42 drugs studied
About Lawrence E. Feldman
Education:
- Earned an MD from the University of Michigan College of Medicine.
- Completed Residency, Internship, and Fellowship at the University of Michigan Medical School.
Experience:
- Board Certified by the American Board of Internal Medicine and American Board of Medical Oncology.
- Specializes in lung, head, and neck cancers at UI Health's Division of Hematology & Oncology.
- Leads research focused on early detection and immunotherapy.
- Active member of the Translational Oncology Program at the University of Illinois.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Lawrence E. Feldman is currently running
ADT + Pembrolizumab
for Salivary Gland Cancer
A Phase II, multi-center, single-arm, non-blinded study combining androgen deprivation therapy (ADT) and pembrolizumab for patients with metastatic or locally recurrent androgen receptor-positive salivary gland carcinoma, not amenable to surgery or radiation.
Recruiting1 award Phase 221 criteria
Cabozantinib + Pembrolizumab
for Lung Cancer
This is a phase II study to assess the efficacy, safety, and Health Related Quality of Life (HRQoL) of combination cabozantinib and pembrolizumab as maintenance therapy for patients with metastatic squamous Non Small Cell Lung Cancer(sqNSCLC) who have received 4 cycles of induction therapy with pembrolizumab, carboplatin, and nab-paclitaxel or paclitaxel
Recruiting1 award Phase 2
More about Lawrence E. Feldman
Clinical Trial Related5 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Lawrence E. Feldman has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Atezolizumab
- Cisplatin
- Pemetrexed
Breakdown of trials Lawrence E. Feldman has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lawrence E. Feldman specialize in?
Lawrence E. Feldman focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Lawrence E. Feldman currently recruiting for clinical trials?
Yes, Lawrence E. Feldman is currently recruiting for 13 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Lawrence E. Feldman has studied deeply?
Yes, Lawrence E. Feldman has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Lawrence E. Feldman?
Apply for one of the trials that Lawrence E. Feldman is conducting.
What is the office address of Lawrence E. Feldman?
The office of Lawrence E. Feldman is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.